| http://www.w3.org/ns/prov#value | - ???Despite our hopes to advance the treatment of this debilitating disease, talampanel did not succeed in demonstrating the required efficacy, although safety was established,??? Teva group VP global branded products Moshe Manor said. ???Broadening our innovative pipeline ??? through internal R&D, licensing and other business development activities ??? is part of our long-term strategy.???
|
